eli lilly glp 1 stock analysis The GLP-1 wars are heating up. Novo Nordisk (NVO) is suing rival (LLY), alleging the drugmaker used outdated clinical trial data in advertising to make its weight loss and diabetes How to Invest in GLP-1
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6























